(Q36004765)

11 August 2017

1 reference

title

Evolving pathogens in vulvovaginal candidiasis: implications for patient care (English)

1 reference

11 August 2017

1 reference

1 reference

vulvovaginal candidiasis

1 reference

B. J. Horowitz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1564129

9 October 2022

D. Giaquinta

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1564129

9 October 2022

S. Ito

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1564129

9 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1564129

9 October 2022

publication date

1 March 1992

1 reference

The Journal of Clinical Pharmacology

11 August 2017

1 reference

11 August 2017

32

1 reference

11 August 2017

3

1 reference

11 August 2017

248-255

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1992.TB03833.X

11 August 2017

1 reference

Epidemiology of recurrent vulvovaginal candidiasis: identification and strain differentiation of Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1992.TB03833.X

Recurrent vulvovaginal candidiasis. A prospective study of the efficacy of maintenance ketoconazole therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1992.TB03833.X

Evidence for a role for secreted aspartate proteinase of Candida albicans in vulvovaginal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1992.TB03833.X

Drug resistance in the opportunistic pathogens Candida albicans and Candida glabrata.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1992.TB03833.X

Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1992.TB03833.X

Candida tropicalis: A Major Pathogen in Immunocompromised Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1992.TB03833.X

Anticandidal activities of terconazole, a broad-spectrum antimycotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1992.TB03833.X

Miconazole, a broad-spectrum antimycotic agent with antibacterial activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1992.TB03833.X

Terconazole - a new broad-spectrum antifungal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1992.TB03833.X

10.1002/J.1552-4604.1992.TB03833.X

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference